Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDDermata Therapeutics, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 1 | -$1.16 | -$1.16 | -$1.16 |
| Q2 2025 | 1 | -$0.44 | -$0.44 | -$0.44 |
| Q3 2025 | 1 | -$0.32 | -$0.32 | -$0.32 |
| Q4 2025 | 1 | -$0.63 | -$0.63 | -$0.63 |
Dermata Therapeutics, Inc. Earnings Date And Information
Dermata Therapeutics, Inc. last posted its earnings results on Wednesday, November 13th, 2024. The company reported $-2.04 earnings per share for the quarter, topping analysts' consensus estimates of $-2.64 by $0.6. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Dermata Therapeutics, Inc. has generated $-40 earnings per share over the last year ($-39.98 diluted earnings per share) and currently has a price-to-earnings ratio of -0.2. Dermata Therapeutics, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, March 31st, 2025 based on prior year's report dates.
Dermata Therapeutics, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/13/2024 | Q3 2024 | -$2.64 | -$2.04 | 0.6 | $0 | $0 |
| 08/07/2024 | Q2 2024 | -$3.79 | -$4.18 | -0.39 | $0 | $0 |
| 03/30/2024 | Q1 2024 | -$7.06 | $0 | |||
| 03/21/2024 | Q4 2023 | -$0.78 | -$0.54 | 0.24 | $0 | |
| 11/09/2023 | Q3 2023 | -$0.63 | -$0.54 | 0.09 | $0 | |
| 08/10/2023 | Q2 2023 | -$0.92 | -$0.63 | 0.29 | $0 | |
| 05/11/2023 | Q1 2023 | -$2.65 | -$2.23 | 0.42 | $0 | |
| 03/28/2023 | Q4 2022 | -$2.06 | $0 | |||
| 11/10/2022 | Q3 2022 | -$3.52 | -$3.10 | 0.42 | $0 | |
| 08/15/2022 | Q2 2022 | -$5.12 | -$3.90 | 1.22 | $0 | |
| 05/16/2022 | Q1 2022 | -$6.40 | -$5.35 | 1.05 | $0 | |
| 03/28/2022 | Q4 2021 | -$5.68 | -$0.31 | 5.37 | $0 | |
| 11/15/2021 | Q3 2021 | -$7.36 | -$5.50 | 1.86 | $0 | |
| 09/27/2021 | Q2 2021 | -$22.56 | -$2.84 | 19.72 | $0 | |
| 03/30/2021 | Q1 2021 | -$4.43 | $0 | |||
| 12/30/2020 | Q4 2020 | -$0.05 | $0 | |||
| 09/29/2020 | Q3 2020 | -$1.15 | $0 | |||
| 06/29/2020 | Q2 2020 | -$1.58 | $0 | |||
| 03/30/2020 | Q1 2020 | -$2.73 | $0 |
Dermata Therapeutics, Inc. Earnings: FAQ's
When is Dermata Therapeutics, Inc.'s earnings date?
Dermata Therapeutics, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, March 31st, 2025 based off last year's report dates.
Did Dermata Therapeutics, Inc. beat their earnings estimates last
quarter?
In the previous quarter, Dermata Therapeutics, Inc. (:DRMA) reported $-2.04 earnings per share (EPS) to beat the analysts' consensus estimate of $-2.64 by $0.6.
How can I listen to Dermata Therapeutics, Inc.'s earnings conference
call?
The conference call for Dermata Therapeutics, Inc.'s latest earnings report can be listened to online.
How can I read Dermata Therapeutics, Inc.'s conference call transcript?
The conference call transcript for Dermata Therapeutics, Inc.'s latest earnings report can be read online.
How much profit does Dermata Therapeutics, Inc. generate each year?
Dermata Therapeutics, Inc. (:DRMA) has a recorded net income of $0. Dermata Therapeutics, Inc. has generated $-40.18 earnings per share over the last four quarters.
What is Dermata Therapeutics, Inc.'s price-to-earnings ratio?
Dermata Therapeutics, Inc. (:DRMA) has a price-to-earnings ratio of -0.2 and price/earnings-to-growth ratio is 0.02.